BOSTON SCIENTIFIC CORP is 6.4x more valuable than GLOBUS MEDICAL INC by market capitalization ($70.11 B vs $10.93 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GMED | BSX |
|---|---|---|
| Market cap | $10.93 B | $70.11 B |
| US-listed rank | #901 | #243 |
| Revenue (latest FY) | $2.94B | $20.07B |
| Net income (latest FY) | $537.87M | - |
| Net margin | 18.3% | - |
| P/E (trailing FY) | 20.3 | - |
| SEC filings | 752 | 1,009 |
BOSTON SCIENTIFIC CORP is 6.4x more valuable than GLOBUS MEDICAL INC by market capitalization ($70.11 B vs $10.93 B).
In their latest fiscal years, GLOBUS MEDICAL INC reported $2.94B in revenue while BOSTON SCIENTIFIC CORP reported $20.07B.
Full pages: GLOBUS MEDICAL INC and BOSTON SCIENTIFIC CORP, or browse the full rankings.